nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—Dronabinol—PTGS1—kidney cancer	0.013	0.417	CrCbGaD
Nabilone—Dronabinol—CYP1A1—kidney cancer	0.0119	0.381	CrCbGaD
Nabilone—Dronabinol—ABCB1—kidney cancer	0.00631	0.202	CrCbGaD
Nabilone—Paraesthesia—Vincristine—kidney cancer	0.000899	0.000937	CcSEcCtD
Nabilone—Agitation—Paclitaxel—kidney cancer	0.000896	0.000933	CcSEcCtD
Nabilone—Rash—Everolimus—kidney cancer	0.000894	0.000931	CcSEcCtD
Nabilone—Dermatitis—Everolimus—kidney cancer	0.000893	0.00093	CcSEcCtD
Nabilone—Headache—Vinblastine—kidney cancer	0.000892	0.000929	CcSEcCtD
Nabilone—Headache—Everolimus—kidney cancer	0.000888	0.000925	CcSEcCtD
Nabilone—Hypotension—Gemcitabine—kidney cancer	0.000888	0.000925	CcSEcCtD
Nabilone—Abdominal pain—Dactinomycin—kidney cancer	0.000886	0.000923	CcSEcCtD
Nabilone—Body temperature increased—Dactinomycin—kidney cancer	0.000886	0.000923	CcSEcCtD
Nabilone—Visual impairment—Capecitabine—kidney cancer	0.000885	0.000922	CcSEcCtD
Nabilone—Asthenia—Sorafenib—kidney cancer	0.000883	0.00092	CcSEcCtD
Nabilone—Malaise—Paclitaxel—kidney cancer	0.000879	0.000916	CcSEcCtD
Nabilone—Vertigo—Paclitaxel—kidney cancer	0.000876	0.000912	CcSEcCtD
Nabilone—Syncope—Paclitaxel—kidney cancer	0.000874	0.000911	CcSEcCtD
Nabilone—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000874	0.00091	CcSEcCtD
Nabilone—Leukopenia—Paclitaxel—kidney cancer	0.000872	0.000909	CcSEcCtD
Nabilone—Hypersensitivity—Sunitinib—kidney cancer	0.000872	0.000909	CcSEcCtD
Nabilone—Decreased appetite—Vincristine—kidney cancer	0.000871	0.000907	CcSEcCtD
Nabilone—Pruritus—Sorafenib—kidney cancer	0.000871	0.000907	CcSEcCtD
Nabilone—Vomiting—Erlotinib—kidney cancer	0.00087	0.000906	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000866	0.000902	CcSEcCtD
Nabilone—Fatigue—Vincristine—kidney cancer	0.000863	0.0009	CcSEcCtD
Nabilone—Rash—Erlotinib—kidney cancer	0.000862	0.000898	CcSEcCtD
Nabilone—Dermatitis—Erlotinib—kidney cancer	0.000862	0.000898	CcSEcCtD
Nabilone—Palpitations—Paclitaxel—kidney cancer	0.000861	0.000897	CcSEcCtD
Nabilone—Insomnia—Gemcitabine—kidney cancer	0.000859	0.000895	CcSEcCtD
Nabilone—Eye disorder—Capecitabine—kidney cancer	0.000859	0.000895	CcSEcCtD
Nabilone—Headache—Erlotinib—kidney cancer	0.000857	0.000893	CcSEcCtD
Nabilone—Tinnitus—Capecitabine—kidney cancer	0.000857	0.000892	CcSEcCtD
Nabilone—Loss of consciousness—Paclitaxel—kidney cancer	0.000857	0.000892	CcSEcCtD
Nabilone—Pain—Vincristine—kidney cancer	0.000856	0.000892	CcSEcCtD
Nabilone—Constipation—Vincristine—kidney cancer	0.000856	0.000892	CcSEcCtD
Nabilone—Paraesthesia—Gemcitabine—kidney cancer	0.000853	0.000889	CcSEcCtD
Nabilone—Flushing—Capecitabine—kidney cancer	0.000853	0.000888	CcSEcCtD
Nabilone—Cough—Paclitaxel—kidney cancer	0.000851	0.000886	CcSEcCtD
Nabilone—Asthenia—Sunitinib—kidney cancer	0.00085	0.000885	CcSEcCtD
Nabilone—Dyspnoea—Gemcitabine—kidney cancer	0.000847	0.000882	CcSEcCtD
Nabilone—Nausea—Vinblastine—kidney cancer	0.000845	0.000881	CcSEcCtD
Nabilone—Somnolence—Gemcitabine—kidney cancer	0.000845	0.00088	CcSEcCtD
Nabilone—Convulsion—Paclitaxel—kidney cancer	0.000844	0.00088	CcSEcCtD
Nabilone—Affect lability—Doxorubicin—kidney cancer	0.000843	0.000878	CcSEcCtD
Nabilone—Nausea—Everolimus—kidney cancer	0.000842	0.000877	CcSEcCtD
Nabilone—Diarrhoea—Sorafenib—kidney cancer	0.000842	0.000877	CcSEcCtD
Nabilone—Hypertension—Paclitaxel—kidney cancer	0.000842	0.000877	CcSEcCtD
Nabilone—Pruritus—Sunitinib—kidney cancer	0.000838	0.000873	CcSEcCtD
Nabilone—Chest pain—Paclitaxel—kidney cancer	0.00083	0.000864	CcSEcCtD
Nabilone—Myalgia—Paclitaxel—kidney cancer	0.00083	0.000864	CcSEcCtD
Nabilone—Arthralgia—Paclitaxel—kidney cancer	0.00083	0.000864	CcSEcCtD
Nabilone—Anxiety—Paclitaxel—kidney cancer	0.000827	0.000861	CcSEcCtD
Nabilone—Face oedema—Doxorubicin—kidney cancer	0.000827	0.000861	CcSEcCtD
Nabilone—Decreased appetite—Gemcitabine—kidney cancer	0.000826	0.00086	CcSEcCtD
Nabilone—Hypersensitivity—Dactinomycin—kidney cancer	0.000826	0.00086	CcSEcCtD
Nabilone—Chills—Capecitabine—kidney cancer	0.000824	0.000859	CcSEcCtD
Nabilone—Arrhythmia—Capecitabine—kidney cancer	0.000821	0.000855	CcSEcCtD
Nabilone—Discomfort—Paclitaxel—kidney cancer	0.00082	0.000854	CcSEcCtD
Nabilone—Fatigue—Gemcitabine—kidney cancer	0.000819	0.000853	CcSEcCtD
Nabilone—Gastrointestinal pain—Vincristine—kidney cancer	0.000819	0.000853	CcSEcCtD
Nabilone—Dizziness—Sorafenib—kidney cancer	0.000814	0.000848	CcSEcCtD
Nabilone—Constipation—Gemcitabine—kidney cancer	0.000812	0.000846	CcSEcCtD
Nabilone—Pain—Gemcitabine—kidney cancer	0.000812	0.000846	CcSEcCtD
Nabilone—Nausea—Erlotinib—kidney cancer	0.000812	0.000846	CcSEcCtD
Nabilone—Dry mouth—Paclitaxel—kidney cancer	0.000812	0.000845	CcSEcCtD
Nabilone—Mood swings—Doxorubicin—kidney cancer	0.000811	0.000845	CcSEcCtD
Nabilone—Diarrhoea—Sunitinib—kidney cancer	0.00081	0.000844	CcSEcCtD
Nabilone—Ataxia—Doxorubicin—kidney cancer	0.000805	0.000839	CcSEcCtD
Nabilone—Asthenia—Dactinomycin—kidney cancer	0.000804	0.000838	CcSEcCtD
Nabilone—Confusional state—Paclitaxel—kidney cancer	0.000802	0.000836	CcSEcCtD
Nabilone—Abdominal pain—Vincristine—kidney cancer	0.000792	0.000825	CcSEcCtD
Nabilone—Body temperature increased—Vincristine—kidney cancer	0.000792	0.000825	CcSEcCtD
Nabilone—Infection—Paclitaxel—kidney cancer	0.00079	0.000823	CcSEcCtD
Nabilone—Dizziness—Sunitinib—kidney cancer	0.000783	0.000816	CcSEcCtD
Nabilone—Feeling abnormal—Gemcitabine—kidney cancer	0.000783	0.000816	CcSEcCtD
Nabilone—Shock—Paclitaxel—kidney cancer	0.000783	0.000815	CcSEcCtD
Nabilone—Vomiting—Sorafenib—kidney cancer	0.000782	0.000815	CcSEcCtD
Nabilone—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000782	0.000815	CcSEcCtD
Nabilone—Tachycardia—Paclitaxel—kidney cancer	0.000776	0.000809	CcSEcCtD
Nabilone—Rash—Sorafenib—kidney cancer	0.000776	0.000808	CcSEcCtD
Nabilone—Dermatitis—Sorafenib—kidney cancer	0.000775	0.000808	CcSEcCtD
Nabilone—Back pain—Capecitabine—kidney cancer	0.000774	0.000806	CcSEcCtD
Nabilone—Headache—Sorafenib—kidney cancer	0.000771	0.000803	CcSEcCtD
Nabilone—Hyperhidrosis—Paclitaxel—kidney cancer	0.000769	0.000801	CcSEcCtD
Nabilone—CNR1—N-cadherin signaling events—CTNNA1—kidney cancer	0.000768	0.0864	CbGpPWpGaD
Nabilone—Diarrhoea—Dactinomycin—kidney cancer	0.000767	0.000799	CcSEcCtD
Nabilone—Anorexia—Paclitaxel—kidney cancer	0.000758	0.00079	CcSEcCtD
Nabilone—Gastritis—Doxorubicin—kidney cancer	0.000758	0.000789	CcSEcCtD
Nabilone—Vision blurred—Capecitabine—kidney cancer	0.000754	0.000785	CcSEcCtD
Nabilone—Vomiting—Sunitinib—kidney cancer	0.000753	0.000784	CcSEcCtD
Nabilone—Body temperature increased—Gemcitabine—kidney cancer	0.000751	0.000782	CcSEcCtD
Nabilone—Tremor—Capecitabine—kidney cancer	0.000749	0.000781	CcSEcCtD
Nabilone—Rash—Sunitinib—kidney cancer	0.000747	0.000778	CcSEcCtD
Nabilone—Dermatitis—Sunitinib—kidney cancer	0.000746	0.000777	CcSEcCtD
Nabilone—Hypotension—Paclitaxel—kidney cancer	0.000743	0.000774	CcSEcCtD
Nabilone—Ill-defined disorder—Capecitabine—kidney cancer	0.000742	0.000773	CcSEcCtD
Nabilone—Headache—Sunitinib—kidney cancer	0.000742	0.000773	CcSEcCtD
Nabilone—Anaemia—Capecitabine—kidney cancer	0.000739	0.00077	CcSEcCtD
Nabilone—Hypersensitivity—Vincristine—kidney cancer	0.000738	0.000769	CcSEcCtD
Nabilone—Nausea—Sorafenib—kidney cancer	0.000731	0.000761	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000725	0.000755	CcSEcCtD
Nabilone—Malaise—Capecitabine—kidney cancer	0.000721	0.000751	CcSEcCtD
Nabilone—Insomnia—Paclitaxel—kidney cancer	0.000719	0.00075	CcSEcCtD
Nabilone—Vertigo—Capecitabine—kidney cancer	0.000719	0.000749	CcSEcCtD
Nabilone—Asthenia—Vincristine—kidney cancer	0.000719	0.000749	CcSEcCtD
Nabilone—Syncope—Capecitabine—kidney cancer	0.000717	0.000747	CcSEcCtD
Nabilone—Leukopenia—Capecitabine—kidney cancer	0.000716	0.000746	CcSEcCtD
Nabilone—Paraesthesia—Paclitaxel—kidney cancer	0.000714	0.000744	CcSEcCtD
Nabilone—Vomiting—Dactinomycin—kidney cancer	0.000713	0.000742	CcSEcCtD
Nabilone—Dyspnoea—Paclitaxel—kidney cancer	0.000709	0.000739	CcSEcCtD
Nabilone—Somnolence—Paclitaxel—kidney cancer	0.000707	0.000737	CcSEcCtD
Nabilone—Palpitations—Capecitabine—kidney cancer	0.000707	0.000736	CcSEcCtD
Nabilone—Rash—Dactinomycin—kidney cancer	0.000707	0.000736	CcSEcCtD
Nabilone—Nausea—Sunitinib—kidney cancer	0.000703	0.000733	CcSEcCtD
Nabilone—Loss of consciousness—Capecitabine—kidney cancer	0.000703	0.000732	CcSEcCtD
Nabilone—Dyspepsia—Paclitaxel—kidney cancer	0.0007	0.000729	CcSEcCtD
Nabilone—Cough—Capecitabine—kidney cancer	0.000698	0.000727	CcSEcCtD
Nabilone—Decreased appetite—Paclitaxel—kidney cancer	0.000692	0.00072	CcSEcCtD
Nabilone—Hypertension—Capecitabine—kidney cancer	0.000691	0.000719	CcSEcCtD
Nabilone—Fatigue—Paclitaxel—kidney cancer	0.000686	0.000714	CcSEcCtD
Nabilone—Diarrhoea—Vincristine—kidney cancer	0.000685	0.000714	CcSEcCtD
Nabilone—Pollakiuria—Doxorubicin—kidney cancer	0.000684	0.000712	CcSEcCtD
Nabilone—Asthenia—Gemcitabine—kidney cancer	0.000682	0.00071	CcSEcCtD
Nabilone—Chest pain—Capecitabine—kidney cancer	0.000681	0.000709	CcSEcCtD
Nabilone—Arthralgia—Capecitabine—kidney cancer	0.000681	0.000709	CcSEcCtD
Nabilone—Myalgia—Capecitabine—kidney cancer	0.000681	0.000709	CcSEcCtD
Nabilone—Constipation—Paclitaxel—kidney cancer	0.00068	0.000709	CcSEcCtD
Nabilone—Pain—Paclitaxel—kidney cancer	0.00068	0.000709	CcSEcCtD
Nabilone—Anxiety—Capecitabine—kidney cancer	0.000679	0.000707	CcSEcCtD
Nabilone—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000675	0.000704	CcSEcCtD
Nabilone—Discomfort—Capecitabine—kidney cancer	0.000673	0.000701	CcSEcCtD
Nabilone—Pruritus—Gemcitabine—kidney cancer	0.000672	0.0007	CcSEcCtD
Nabilone—Dry mouth—Capecitabine—kidney cancer	0.000666	0.000694	CcSEcCtD
Nabilone—Nausea—Dactinomycin—kidney cancer	0.000666	0.000694	CcSEcCtD
Nabilone—Dizziness—Vincristine—kidney cancer	0.000662	0.00069	CcSEcCtD
Nabilone—Drowsiness—Doxorubicin—kidney cancer	0.00066	0.000687	CcSEcCtD
Nabilone—Confusional state—Capecitabine—kidney cancer	0.000658	0.000686	CcSEcCtD
Nabilone—Feeling abnormal—Paclitaxel—kidney cancer	0.000656	0.000683	CcSEcCtD
Nabilone—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00065	0.000678	CcSEcCtD
Nabilone—Diarrhoea—Gemcitabine—kidney cancer	0.00065	0.000677	CcSEcCtD
Nabilone—Infection—Capecitabine—kidney cancer	0.000649	0.000676	CcSEcCtD
Nabilone—Stomatitis—Doxorubicin—kidney cancer	0.000643	0.00067	CcSEcCtD
Nabilone—Shock—Capecitabine—kidney cancer	0.000642	0.000669	CcSEcCtD
Nabilone—Tachycardia—Capecitabine—kidney cancer	0.000637	0.000664	CcSEcCtD
Nabilone—Vomiting—Vincristine—kidney cancer	0.000637	0.000663	CcSEcCtD
Nabilone—Rash—Vincristine—kidney cancer	0.000631	0.000658	CcSEcCtD
Nabilone—Hyperhidrosis—Capecitabine—kidney cancer	0.000631	0.000657	CcSEcCtD
Nabilone—Dermatitis—Vincristine—kidney cancer	0.000631	0.000657	CcSEcCtD
Nabilone—Abdominal pain—Paclitaxel—kidney cancer	0.000629	0.000655	CcSEcCtD
Nabilone—Body temperature increased—Paclitaxel—kidney cancer	0.000629	0.000655	CcSEcCtD
Nabilone—Headache—Vincristine—kidney cancer	0.000627	0.000654	CcSEcCtD
Nabilone—Epistaxis—Doxorubicin—kidney cancer	0.000622	0.000648	CcSEcCtD
Nabilone—Anorexia—Capecitabine—kidney cancer	0.000622	0.000648	CcSEcCtD
Nabilone—Hypotension—Capecitabine—kidney cancer	0.00061	0.000635	CcSEcCtD
Nabilone—Vomiting—Gemcitabine—kidney cancer	0.000604	0.000629	CcSEcCtD
Nabilone—Rash—Gemcitabine—kidney cancer	0.000599	0.000624	CcSEcCtD
Nabilone—Dermatitis—Gemcitabine—kidney cancer	0.000599	0.000623	CcSEcCtD
Nabilone—Headache—Gemcitabine—kidney cancer	0.000595	0.00062	CcSEcCtD
Nabilone—Nausea—Vincristine—kidney cancer	0.000595	0.00062	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000595	0.00062	CcSEcCtD
Nabilone—Insomnia—Capecitabine—kidney cancer	0.00059	0.000615	CcSEcCtD
Nabilone—Hypoaesthesia—Doxorubicin—kidney cancer	0.000589	0.000614	CcSEcCtD
Nabilone—Pharyngitis—Doxorubicin—kidney cancer	0.000588	0.000612	CcSEcCtD
Nabilone—Paraesthesia—Capecitabine—kidney cancer	0.000586	0.000611	CcSEcCtD
Nabilone—Hypersensitivity—Paclitaxel—kidney cancer	0.000586	0.000611	CcSEcCtD
Nabilone—Dyspnoea—Capecitabine—kidney cancer	0.000582	0.000606	CcSEcCtD
Nabilone—Dyspepsia—Capecitabine—kidney cancer	0.000575	0.000599	CcSEcCtD
Nabilone—Visual impairment—Doxorubicin—kidney cancer	0.000571	0.000595	CcSEcCtD
Nabilone—Asthenia—Paclitaxel—kidney cancer	0.000571	0.000595	CcSEcCtD
Nabilone—Decreased appetite—Capecitabine—kidney cancer	0.000567	0.000591	CcSEcCtD
Nabilone—Nausea—Gemcitabine—kidney cancer	0.000564	0.000588	CcSEcCtD
Nabilone—Fatigue—Capecitabine—kidney cancer	0.000563	0.000586	CcSEcCtD
Nabilone—Pruritus—Paclitaxel—kidney cancer	0.000563	0.000586	CcSEcCtD
Nabilone—Pain—Capecitabine—kidney cancer	0.000558	0.000582	CcSEcCtD
Nabilone—Constipation—Capecitabine—kidney cancer	0.000558	0.000582	CcSEcCtD
Nabilone—Eye disorder—Doxorubicin—kidney cancer	0.000554	0.000577	CcSEcCtD
Nabilone—Tinnitus—Doxorubicin—kidney cancer	0.000552	0.000575	CcSEcCtD
Nabilone—Flushing—Doxorubicin—kidney cancer	0.00055	0.000573	CcSEcCtD
Nabilone—Diarrhoea—Paclitaxel—kidney cancer	0.000544	0.000567	CcSEcCtD
Nabilone—Feeling abnormal—Capecitabine—kidney cancer	0.000538	0.00056	CcSEcCtD
Nabilone—Gastrointestinal pain—Capecitabine—kidney cancer	0.000534	0.000556	CcSEcCtD
Nabilone—Chills—Doxorubicin—kidney cancer	0.000531	0.000554	CcSEcCtD
Nabilone—Arrhythmia—Doxorubicin—kidney cancer	0.000529	0.000551	CcSEcCtD
Nabilone—Dizziness—Paclitaxel—kidney cancer	0.000526	0.000548	CcSEcCtD
Nabilone—Body temperature increased—Capecitabine—kidney cancer	0.000516	0.000538	CcSEcCtD
Nabilone—Abdominal pain—Capecitabine—kidney cancer	0.000516	0.000538	CcSEcCtD
Nabilone—Tension—Doxorubicin—kidney cancer	0.000506	0.000527	CcSEcCtD
Nabilone—Vomiting—Paclitaxel—kidney cancer	0.000506	0.000527	CcSEcCtD
Nabilone—Rash—Paclitaxel—kidney cancer	0.000502	0.000522	CcSEcCtD
Nabilone—Dermatitis—Paclitaxel—kidney cancer	0.000501	0.000522	CcSEcCtD
Nabilone—Nervousness—Doxorubicin—kidney cancer	0.000501	0.000522	CcSEcCtD
Nabilone—Back pain—Doxorubicin—kidney cancer	0.000499	0.00052	CcSEcCtD
Nabilone—Headache—Paclitaxel—kidney cancer	0.000498	0.000519	CcSEcCtD
Nabilone—Vision blurred—Doxorubicin—kidney cancer	0.000486	0.000506	CcSEcCtD
Nabilone—Hypersensitivity—Capecitabine—kidney cancer	0.000481	0.000501	CcSEcCtD
Nabilone—Ill-defined disorder—Doxorubicin—kidney cancer	0.000478	0.000498	CcSEcCtD
Nabilone—Anaemia—Doxorubicin—kidney cancer	0.000477	0.000496	CcSEcCtD
Nabilone—Agitation—Doxorubicin—kidney cancer	0.000474	0.000494	CcSEcCtD
Nabilone—Nausea—Paclitaxel—kidney cancer	0.000473	0.000492	CcSEcCtD
Nabilone—Asthenia—Capecitabine—kidney cancer	0.000468	0.000488	CcSEcCtD
Nabilone—Malaise—Doxorubicin—kidney cancer	0.000465	0.000484	CcSEcCtD
Nabilone—Vertigo—Doxorubicin—kidney cancer	0.000463	0.000483	CcSEcCtD
Nabilone—Syncope—Doxorubicin—kidney cancer	0.000462	0.000482	CcSEcCtD
Nabilone—Pruritus—Capecitabine—kidney cancer	0.000462	0.000481	CcSEcCtD
Nabilone—Leukopenia—Doxorubicin—kidney cancer	0.000462	0.000481	CcSEcCtD
Nabilone—Palpitations—Doxorubicin—kidney cancer	0.000456	0.000475	CcSEcCtD
Nabilone—Loss of consciousness—Doxorubicin—kidney cancer	0.000453	0.000472	CcSEcCtD
Nabilone—Cough—Doxorubicin—kidney cancer	0.00045	0.000469	CcSEcCtD
Nabilone—Convulsion—Doxorubicin—kidney cancer	0.000447	0.000465	CcSEcCtD
Nabilone—Diarrhoea—Capecitabine—kidney cancer	0.000447	0.000465	CcSEcCtD
Nabilone—Hypertension—Doxorubicin—kidney cancer	0.000445	0.000464	CcSEcCtD
Nabilone—Myalgia—Doxorubicin—kidney cancer	0.000439	0.000457	CcSEcCtD
Nabilone—Arthralgia—Doxorubicin—kidney cancer	0.000439	0.000457	CcSEcCtD
Nabilone—Chest pain—Doxorubicin—kidney cancer	0.000439	0.000457	CcSEcCtD
Nabilone—Anxiety—Doxorubicin—kidney cancer	0.000437	0.000456	CcSEcCtD
Nabilone—Discomfort—Doxorubicin—kidney cancer	0.000434	0.000452	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—EEF2—kidney cancer	0.000433	0.0488	CbGpPWpGaD
Nabilone—Dizziness—Capecitabine—kidney cancer	0.000432	0.00045	CcSEcCtD
Nabilone—Dry mouth—Doxorubicin—kidney cancer	0.000429	0.000447	CcSEcCtD
Nabilone—Confusional state—Doxorubicin—kidney cancer	0.000424	0.000442	CcSEcCtD
Nabilone—Infection—Doxorubicin—kidney cancer	0.000418	0.000435	CcSEcCtD
Nabilone—Vomiting—Capecitabine—kidney cancer	0.000415	0.000432	CcSEcCtD
Nabilone—Shock—Doxorubicin—kidney cancer	0.000414	0.000431	CcSEcCtD
Nabilone—Rash—Capecitabine—kidney cancer	0.000412	0.000429	CcSEcCtD
Nabilone—Dermatitis—Capecitabine—kidney cancer	0.000411	0.000428	CcSEcCtD
Nabilone—Tachycardia—Doxorubicin—kidney cancer	0.000411	0.000428	CcSEcCtD
Nabilone—Headache—Capecitabine—kidney cancer	0.000409	0.000426	CcSEcCtD
Nabilone—Hyperhidrosis—Doxorubicin—kidney cancer	0.000407	0.000424	CcSEcCtD
Nabilone—Anorexia—Doxorubicin—kidney cancer	0.000401	0.000418	CcSEcCtD
Nabilone—Hypotension—Doxorubicin—kidney cancer	0.000393	0.00041	CcSEcCtD
Nabilone—Nausea—Capecitabine—kidney cancer	0.000388	0.000404	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000383	0.000399	CcSEcCtD
Nabilone—Insomnia—Doxorubicin—kidney cancer	0.000381	0.000396	CcSEcCtD
Nabilone—Paraesthesia—Doxorubicin—kidney cancer	0.000378	0.000394	CcSEcCtD
Nabilone—Dyspnoea—Doxorubicin—kidney cancer	0.000375	0.000391	CcSEcCtD
Nabilone—Somnolence—Doxorubicin—kidney cancer	0.000374	0.00039	CcSEcCtD
Nabilone—Dyspepsia—Doxorubicin—kidney cancer	0.00037	0.000386	CcSEcCtD
Nabilone—Decreased appetite—Doxorubicin—kidney cancer	0.000366	0.000381	CcSEcCtD
Nabilone—Fatigue—Doxorubicin—kidney cancer	0.000363	0.000378	CcSEcCtD
Nabilone—Constipation—Doxorubicin—kidney cancer	0.00036	0.000375	CcSEcCtD
Nabilone—Pain—Doxorubicin—kidney cancer	0.00036	0.000375	CcSEcCtD
Nabilone—Feeling abnormal—Doxorubicin—kidney cancer	0.000347	0.000361	CcSEcCtD
Nabilone—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000344	0.000358	CcSEcCtD
Nabilone—Abdominal pain—Doxorubicin—kidney cancer	0.000333	0.000347	CcSEcCtD
Nabilone—Body temperature increased—Doxorubicin—kidney cancer	0.000333	0.000347	CcSEcCtD
Nabilone—Hypersensitivity—Doxorubicin—kidney cancer	0.00031	0.000323	CcSEcCtD
Nabilone—Asthenia—Doxorubicin—kidney cancer	0.000302	0.000315	CcSEcCtD
Nabilone—Pruritus—Doxorubicin—kidney cancer	0.000298	0.00031	CcSEcCtD
Nabilone—Diarrhoea—Doxorubicin—kidney cancer	0.000288	0.0003	CcSEcCtD
Nabilone—Dizziness—Doxorubicin—kidney cancer	0.000278	0.00029	CcSEcCtD
Nabilone—Vomiting—Doxorubicin—kidney cancer	0.000268	0.000279	CcSEcCtD
Nabilone—Rash—Doxorubicin—kidney cancer	0.000265	0.000276	CcSEcCtD
Nabilone—Dermatitis—Doxorubicin—kidney cancer	0.000265	0.000276	CcSEcCtD
Nabilone—Headache—Doxorubicin—kidney cancer	0.000264	0.000275	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—EIF4EBP1—kidney cancer	0.000252	0.0283	CbGpPWpGaD
Nabilone—Nausea—Doxorubicin—kidney cancer	0.00025	0.00026	CcSEcCtD
Nabilone—CNR1—N-cadherin signaling events—CTNNB1—kidney cancer	0.000248	0.0279	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—OR4C13—kidney cancer	0.000233	0.0262	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—OR4C13—kidney cancer	0.000212	0.0238	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—ANXA1—kidney cancer	0.000202	0.0227	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—EGR1—kidney cancer	0.000197	0.0221	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—OR4C13—kidney cancer	0.000183	0.0206	CbGpPWpGaD
Nabilone—CNR1—N-cadherin signaling events—PIK3CA—kidney cancer	0.000171	0.0192	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—OR4C13—kidney cancer	0.000166	0.0187	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	0.00016	0.018	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—ANXA1—kidney cancer	0.000158	0.0178	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—TSC2—kidney cancer	0.000136	0.0154	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	0.000126	0.0142	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—OR4C13—kidney cancer	0.000125	0.0141	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—ANXA1—kidney cancer	0.000122	0.0137	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—APC—kidney cancer	0.00012	0.0136	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—LATS1—kidney cancer	0.000106	0.012	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—POMC—kidney cancer	9.88e-05	0.0111	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—OR4C13—kidney cancer	9.81e-05	0.011	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AKAP13—kidney cancer	9.68e-05	0.0109	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—ANXA1—kidney cancer	9.58e-05	0.0108	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—RAF1—kidney cancer	9.46e-05	0.0106	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—RELA—kidney cancer	9.41e-05	0.0106	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—MTOR—kidney cancer	9.23e-05	0.0104	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AMER1—kidney cancer	9.04e-05	0.0102	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AKAP13—kidney cancer	8.79e-05	0.00989	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—LATS1—kidney cancer	8.34e-05	0.00939	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—JUN—kidney cancer	8.25e-05	0.00928	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—ITPR2—kidney cancer	8.23e-05	0.00926	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—CTNNB1—kidney cancer	8.18e-05	0.00921	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	7.85e-05	0.00884	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—POMC—kidney cancer	7.75e-05	0.00872	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AKAP13—kidney cancer	7.6e-05	0.00855	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GPC3—kidney cancer	7.58e-05	0.00853	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CER1—kidney cancer	7.58e-05	0.00853	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—ITPR2—kidney cancer	7.48e-05	0.00841	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AMER1—kidney cancer	7.1e-05	0.00798	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—AKAP13—kidney cancer	6.9e-05	0.00776	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—ANXA1—kidney cancer	6.9e-05	0.00776	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—MAPK3—kidney cancer	6.82e-05	0.00767	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—MAPK1—kidney cancer	6.49e-05	0.0073	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—ITPR2—kidney cancer	6.46e-05	0.00727	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SFRP2—kidney cancer	6.44e-05	0.00725	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—ANXA1—kidney cancer	6.26e-05	0.00705	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	6.16e-05	0.00693	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—POMC—kidney cancer	5.98e-05	0.00673	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CER1—kidney cancer	5.95e-05	0.00669	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GPC3—kidney cancer	5.95e-05	0.00669	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—ITPR2—kidney cancer	5.87e-05	0.0066	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—ANXA1—kidney cancer	5.41e-05	0.00609	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CASP2—kidney cancer	5.19e-05	0.00584	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AKAP13—kidney cancer	5.19e-05	0.00584	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SFRP2—kidney cancer	5.06e-05	0.00569	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—ANXA1—kidney cancer	4.92e-05	0.00553	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GRB7—kidney cancer	4.75e-05	0.00534	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—POMC—kidney cancer	4.69e-05	0.00528	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ITPR2—kidney cancer	4.42e-05	0.00497	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CASP2—kidney cancer	4.08e-05	0.00459	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AKAP13—kidney cancer	4.08e-05	0.00459	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CTNNA1—kidney cancer	4e-05	0.0045	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HSPB1—kidney cancer	3.98e-05	0.00448	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EIF4EBP1—kidney cancer	3.98e-05	0.00448	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GRB7—kidney cancer	3.73e-05	0.00419	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PSMD7—kidney cancer	3.7e-05	0.00416	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TSC1—kidney cancer	3.7e-05	0.00416	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ANXA1—kidney cancer	3.7e-05	0.00416	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FLT1—kidney cancer	3.58e-05	0.00403	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ITPR2—kidney cancer	3.47e-05	0.0039	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—POMC—kidney cancer	3.38e-05	0.0038	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—JUNB—kidney cancer	3.32e-05	0.00374	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PAK1—kidney cancer	3.32e-05	0.00374	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CTNNA1—kidney cancer	3.14e-05	0.00353	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HSPB1—kidney cancer	3.12e-05	0.00351	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EIF4EBP1—kidney cancer	3.12e-05	0.00351	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—POMC—kidney cancer	3.07e-05	0.00345	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PSMD7—kidney cancer	2.9e-05	0.00327	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TSC1—kidney cancer	2.9e-05	0.00327	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ANXA1—kidney cancer	2.9e-05	0.00327	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FLT1—kidney cancer	2.81e-05	0.00316	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IGF2—kidney cancer	2.72e-05	0.00306	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CDKN2B—kidney cancer	2.7e-05	0.00304	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—POMC—kidney cancer	2.65e-05	0.00298	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IGF1R—kidney cancer	2.63e-05	0.00296	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PAK1—kidney cancer	2.61e-05	0.00293	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—JUNB—kidney cancer	2.61e-05	0.00293	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—RAF1—kidney cancer	2.53e-05	0.00285	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—IL2—kidney cancer	2.5e-05	0.00281	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—POMC—kidney cancer	2.41e-05	0.00271	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—IL2—kidney cancer	2.27e-05	0.00255	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HIF1A—kidney cancer	2.16e-05	0.00243	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TSC2—kidney cancer	2.16e-05	0.00243	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IGF2—kidney cancer	2.13e-05	0.0024	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CDKN2B—kidney cancer	2.12e-05	0.00239	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—KDR—kidney cancer	2.07e-05	0.00233	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IGF1R—kidney cancer	2.06e-05	0.00232	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—RAF1—kidney cancer	1.99e-05	0.00223	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—IL2—kidney cancer	1.96e-05	0.00221	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—KIT—kidney cancer	1.9e-05	0.00214	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—APC—kidney cancer	1.9e-05	0.00214	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—MAPK3—kidney cancer	1.82e-05	0.00205	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—POMC—kidney cancer	1.81e-05	0.00204	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—BRAF—kidney cancer	1.79e-05	0.00201	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL2—kidney cancer	1.78e-05	0.002	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—MAPK1—kidney cancer	1.74e-05	0.00195	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HIF1A—kidney cancer	1.7e-05	0.00191	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TSC2—kidney cancer	1.69e-05	0.0019	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PIK3CA—kidney cancer	1.66e-05	0.00187	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—KRAS—kidney cancer	1.64e-05	0.00184	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—KDR—kidney cancer	1.62e-05	0.00183	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PIK3CA—kidney cancer	1.51e-05	0.00169	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RAF1—kidney cancer	1.49e-05	0.00168	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—KIT—kidney cancer	1.49e-05	0.00168	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APC—kidney cancer	1.49e-05	0.00168	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RELA—kidney cancer	1.49e-05	0.00167	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ERBB2—kidney cancer	1.48e-05	0.00166	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MTOR—kidney cancer	1.46e-05	0.00164	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—MAPK3—kidney cancer	1.43e-05	0.00161	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—POMC—kidney cancer	1.42e-05	0.0016	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—BRAF—kidney cancer	1.4e-05	0.00158	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CDKN1B—kidney cancer	1.37e-05	0.00154	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—MAPK1—kidney cancer	1.36e-05	0.00153	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL2—kidney cancer	1.34e-05	0.00151	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCND1—kidney cancer	1.31e-05	0.00147	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—JUN—kidney cancer	1.3e-05	0.00147	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3CA—kidney cancer	1.3e-05	0.00146	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CTNNB1—kidney cancer	1.29e-05	0.00146	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—KRAS—kidney cancer	1.29e-05	0.00145	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PTEN—kidney cancer	1.26e-05	0.00142	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3CA—kidney cancer	1.18e-05	0.00133	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RAF1—kidney cancer	1.17e-05	0.00132	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RELA—kidney cancer	1.17e-05	0.00131	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ERBB2—kidney cancer	1.16e-05	0.00131	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MTOR—kidney cancer	1.15e-05	0.00129	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—VEGFA—kidney cancer	1.14e-05	0.00128	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MAPK3—kidney cancer	1.08e-05	0.00121	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CDKN1B—kidney cancer	1.07e-05	0.00121	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL2—kidney cancer	1.05e-05	0.00118	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MYC—kidney cancer	1.05e-05	0.00118	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCND1—kidney cancer	1.03e-05	0.00115	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MAPK1—kidney cancer	1.03e-05	0.00115	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—JUN—kidney cancer	1.02e-05	0.00115	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CTNNB1—kidney cancer	1.02e-05	0.00114	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PTEN—kidney cancer	9.9e-06	0.00111	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—KRAS—kidney cancer	9.68e-06	0.00109	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—VEGFA—kidney cancer	8.94e-06	0.00101	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CA—kidney cancer	8.9e-06	0.001	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TP53—kidney cancer	8.61e-06	0.000968	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MAPK3—kidney cancer	8.46e-06	0.000951	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MYC—kidney cancer	8.22e-06	0.000925	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MAPK1—kidney cancer	8.05e-06	0.000905	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—KRAS—kidney cancer	7.6e-06	0.000855	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CA—kidney cancer	6.98e-06	0.000786	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TP53—kidney cancer	6.75e-06	0.00076	CbGpPWpGaD
